Bryan Johnson Quits Longevity Drug Due to Side Effects
Venture capitalist Bryan Johnson stopped taking the drug rapamycin in September 2024 following side effects such as skin infections and abnormal blood lipids, according to Scientific American. This reversal underscores a growing divide between Silicon Valley’s rapid self-experimentation and the slower, more rigorous process of clinical longevity research. Why are tech influencers testing unproven longevity … Read more